Alkem Laboratories

4,720.00
-21.70
(-0.46%)
Market Cap
56,434.68 Cr
EPS
150.19
PE Ratio
26.22
Dividend Yield
0.84 %
Industry
Healthcare
52 Week High
6,439.90
52 Week low
4,407.05
PB Ratio
4.93
Debt to Equity
0.15
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from18 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy33.33 %
33.33 %
Hold33.33 %
33.33 %
Sell33.33 %
33.33 %
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,669.30 4,00,520.99 34.13 49,887.20 12.06 9,648 13.77 37.74
5,978.30 1,58,705.08 76.14 8,184.00 0.89 1,600 64.53 51.57
1,479.70 1,19,502.65 23.70 26,520.70 14.17 4,155 47.38 51.15
3,095.95 1,04,781.02 56.64 10,785.70 11.59 1,656 13.54 45.77
1,170.95 97,705.34 18.09 28,905.40 12.36 5,578 1.69 30.83
2,348.45 96,889.27 47.77 10,615.60 19.57 1,942 -16.38 39.42
899.65 90,525.84 19.78 19,831.50 13.82 3,831 29.92 36.77
1,977.50 90,213.07 31.46 20,141.50 19.94 1,936 38.82 38.83
1,121.25 65,122.38 18.72 29,559.20 17.55 3,169 -10.04 42.81
29,429.65 62,535.95 47.37 6,097.20 10.80 1,201 16.01 61.56
Growth Rate
Revenue Growth
9.84 %
Net Income Growth
79.93 %
Cash Flow Change
15.78 %
ROE
58.48 %
ROCE
31.25 %
EBITDA Margin (Avg.)
27.51 %

Quarterly Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
944
1,244
1,432
1,290
1,252
1,509
1,672
1,507
1,276
1,342
1,889
1,765
1,521
1,686
1,943
1,934
1,882
1,867
2,296
2,210
2,077
2,047
2,398
2,415
2,238
2,778
2,842
2,673
2,504
2,628
3,130
3,086
2,971
3,034
3,503
3,418
3,024
3,152
3,549
3,467
Expenses
777
1,001
1,127
1,052
993
1,210
1,328
1,214
1,102
1,218
1,405
1,381
1,389
1,455
1,555
1,613
1,619
1,585
1,811
1,729
1,746
1,470
1,762
1,789
1,901
2,139
2,176
2,121
2,162
2,373
2,626
2,442
2,652
2,579
2,751
2,668
2,546
2,423
2,662
2,615
EBITDA
167
242
306
238
260
299
344
294
174
124
485
384
132
231
388
321
263
282
484
481
331
577
636
626
337
640
666
552
343
255
505
644
319
455
752
750
478
729
887
852
Operating Profit %
13 %
16 %
17 %
17 %
14 %
18 %
19 %
18 %
12 %
7 %
24 %
21 %
7 %
12 %
19 %
16 %
13 %
14 %
20 %
21 %
15 %
26 %
25 %
23 %
13 %
22 %
22 %
19 %
13 %
8 %
15 %
20 %
9 %
13 %
20 %
20 %
13 %
20 %
22 %
23 %
Depreciation
18
21
26
23
24
23
26
26
26
31
35
38
40
43
46
48
57
56
56
60
81
67
70
69
69
71
73
78
83
76
77
78
78
72
74
70
83
81
79
85
Interest
17
23
20
19
10
10
12
12
11
13
18
15
10
16
16
15
7
16
18
17
14
17
18
13
11
13
12
11
17
27
25
27
29
30
30
26
27
29
28
36
Profit Before Tax
150
211
280
213
225
266
307
255
136
81
432
332
81
172
326
258
199
210
410
405
235
493
548
543
258
556
582
464
243
152
402
539
212
353
648
655
367
619
780
731
Tax
19
7
8
23
139
23
19
19
-1
17
105
152
15
35
66
53
28
23
29
15
44
70
66
80
9
76
23
-69
135
20
55
79
144
65
33
51
63
69
78
90
Net Profit
132
204
272
190
87
243
288
236
137
64
327
181
66
137
260
205
171
187
381
390
192
423
482
464
249
480
559
533
108
131
348
460
68
288
615
604
305
550
702
641
EPS in ₹
11.00
16.82
22.32
15.63
7.25
19.97
23.65
19.52
11.46
5.99
26.82
14.36
5.61
11.39
21.28
16.94
14.00
15.51
31.02
31.95
15.79
35.30
39.48
37.72
20.07
39.15
45.52
43.96
9.00
10.68
27.67
38.03
5.94
23.98
51.90
49.76
24.55
45.60
57.60
52.34

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
5,296
5,535
6,568
7,666
8,208
9,946
11,519
14,069
13,757
15,575
Fixed Assets
1,374
1,450
1,797
2,284
2,530
2,908
2,793
2,902
2,683
2,873
Current Assets
2,338
2,769
2,917
4,013
4,216
5,506
6,923
8,435
8,730
10,412
Capital Work in Progress
111
172
299
381
493
363
393
340
323
159
Investments
61
509
553
444
324
261
333
371
622
484
Other Assets
3,750
3,404
3,919
4,557
4,861
6,413
8,000
10,457
10,129
12,060
Total Liabilities
5,296
5,535
6,568
7,666
8,208
9,946
11,519
14,069
13,757
15,575
Current Liabilities
2,006
1,538
1,690
2,383
2,218
3,245
3,604
4,805
3,707
3,995
Non Current Liabilities
205
210
296
297
419
392
357
417
615
866
Total Equity
3,085
3,787
4,583
4,985
5,572
6,309
7,558
8,847
9,435
10,714
Reserve & Surplus
2,975
3,668
4,444
4,840
5,415
6,137
7,353
8,614
9,021
10,288
Share Capital
24
24
24
24
24
24
24
24
24
24

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
39
3
40
0
82
-73
-2
58
42
-208
Investing Activities
-235
205
-294
-351
-318
-737
-995
-1,433
120
-1,011
Operating Activities
326
726
471
266
780
585
1,265
1,111
1,683
1,948
Financing Activities
-52
-927
-138
85
-379
79
-272
380
-1,761
-1,145

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
60.16 %
58.84 %
58.84 %
57.13 %
57.13 %
57.14 %
57.16 %
57.16 %
57.16 %
57.16 %
56.74 %
56.74 %
56.74 %
56.38 %
55.66 %
55.66 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
9.11 %
8.69 %
9.02 %
10.15 %
DIIs
12.97 %
14.28 %
13.78 %
13.76 %
13.93 %
13.88 %
15.26 %
16.44 %
16.69 %
15.43 %
17.64 %
14.94 %
15.63 %
18.57 %
19.21 %
18.01 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
21.75 %
21.70 %
21.15 %
22.85 %
22.63 %
22.33 %
22.28 %
21.74 %
21.44 %
20.61 %
19.36 %
18.60 %
18.31 %
16.15 %
15.84 %
15.90 %
Others
5.12 %
5.17 %
6.23 %
6.26 %
6.31 %
6.65 %
5.30 %
4.67 %
4.71 %
6.80 %
6.26 %
9.72 %
0.21 %
0.21 %
0.26 %
0.28 %
No of Share Holders
92,594
93,540
87,392
86,881
81,869
84,104
79,721
76,516
73,440
66,790
69,442
65,184
65,830
69,627
74,744
84,038

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 15 13 16 25 30 34 50 40 0.00
Dividend Yield (%) 0.00 0.75 0.74 0.69 0.9 0.83 1.03 1.01 0.85 0.00

Corporate Action

Announcements

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
2 days ago
Announcement Under Regulation 30 Of SEBI LODR- Regulatory Order
2 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
3 days ago
Announcement Under Regulation 30 Of SEBI LODR- Regulatory Order
6 days ago
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
9 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
10 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Feb 07, 2025, 18:31
Announcement under Regulation 30 (LODR)-Newspaper Publication
Feb 07, 2025, 16:29
Results- Financial Results For Quarter Ended Dec 31 2024
Feb 07, 2025, 14:14
Integrated Filing (Financial)
Feb 07, 2025, 14:09
Announcement under Regulation 30 (LODR)-Acquisition
Feb 07, 2025, 14:04
Announcement under Regulation 30 (LODR)-Acquisition
Feb 07, 2025, 14:01
Closure of Trading Window
Feb 07, 2025, 13:57
Announcement under Regulation 30 (LODR)-Investor Presentation
Feb 07, 2025, 13:55
Corporate Action-Board approves Dividend
Feb 07, 2025, 13:51
Results- Financials Results For Quarter Ended Dec 31 2024
Feb 07, 2025, 13:49
Board Meeting Outcome for Outcome Of The Board Meeting Dated 07/02/2025
Feb 07, 2025, 13:46
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Feb 04, 2025, 16:27
Announcement Under Regulation 30 Of SEBI LODR- Regulatory Order
Feb 04, 2025, 12:17
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 03, 2025, 10:49
Announcement Under Regulation 30 Of SEBI LODR- Regulatory Order
Feb 03, 2025, 10:27
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Jan 30, 2025, 13:12
Announcement under Regulation 30 (LODR)-Updates on Acquisition
Jan 29, 2025, 17:00
Corporate Action - Fixes Record Date For Interim Dividend
Jan 28, 2025, 15:47
Corporate Action-Board to consider Dividend
Jan 28, 2025, 15:43
Board Meeting Intimation for Notice Of Meeting Of Board Of Directors Of Alkem Laboratories Limited.
Jan 28, 2025, 15:39
Intimation Under Regulation 30 Of SEBI LODR Regulations 2015 Regarding Approval For Sale And Transfer Of The Companys Manufacturing Facility Situated At Indore Madhya Pradesh On A Slump Sale Basis.
Jan 07, 2025, 11:22
Announcement Under Regulation 30 Of SEBI LODR- Regulatory Order
Jan 07, 2025, 10:31
Intimation Regarding Change In Name Of Registrar And Share Transfer Agent Of The Company.
Jan 02, 2025, 13:39
Announcement Under Regulation 30 Of SEBI LODR- Regulatory Order
Dec 28, 2024, 14:30
Announcement Under Regulation 30Of SEBI LODR- Regulatory Order
Dec 28, 2024, 09:48
Announcement under Regulation 30 (LODR)-Newspaper Publication
Dec 18, 2024, 17:07

Technical Indicators